Healthcare is now the best-performing sector of 2018. We highlight two top-ranked ETFs suitable for long-term investors.
Investors are dumping muni bond ETFs but things could brighten up in the coming days.
Now might be a good time to think about buying AMZN stock before Amazon reports its Q3 financial results on Thursday, October 25.
Invesco's (IVZ) Q3 earnings show growth in assets under management. The deal to acquire OppenheimerFunds is expected to further support its profitability.
A quality value stock isn't just one that has sold off. This powerhouse screen finds the best stocks with classic value fundamentals.
Philip Morris's (PM) revenues in Q3 benefit from strong pricing and brands in the combustible category.
Financial Technology Industry Outlook: Momentum Continues
Genuine Parts (GPC) revises its 2018 adjusted earnings per share expectation of $5.60-$5.70 from the earlier expectation of $5.60-$5.75.
Top Analyst Reports for AstraZeneca, Salesforce & Mastercard
Puma Biotech (PBYI) focuses on improving sales of its flagship and the only approved product Nerlynx. The drug's label expansion programs also appear promising.
Nucor's (NUE) steel mills unit performed impressively in Q3 but earnings missed expectations. It expects Q4 earnings to decrease across all three operating segments sequentially.
Copa Holdings' (CPA) September traffic rises on higher demand for air travel. However, load factor declines as capacity expansion outpaces traffic growth.
Enphase Energy (ENPH) collaborates with BayWa to gain from the spurt in demand for solar microinverters across the Southeast Asian region.
Wall Street will be tuning into the earnings reports on these 5 companies this week.
Zayo (ZAYO) consistently grows its global reach by expanding fiber foothold and forging strategic partnerships with local providers.
Bio-Techne (TECH) believes that its Chinese collaboration is a strategic fit as it will solidify the integration of microfluidic technology for more apt POC diagnostic tools for precision medicine.
PYPL is currently in the midst of a turbulent six months, but that could change with a big Q3. So, let's see what to expect from PayPal.
Carter's (CRI) displays strength riding on a solid surprise trend, robust outlook and long-term strategies. However, a tepid wholesale business and higher costs are persistent woes.
Kellogg's (K) is on-track with savings initiatives. Also, the company is gaining from the acquisitions of RXBAR, Pringles and the consolidation of Multipro.
DexCom (DXCM) benefits from the diabetes care space as it adopts cloud-based services for Continuous Glucose Monitoring.